ロード中...
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
Drug induced liver injury (DILI) is a rare but well recognized serious adverse reaction. Pre-marketing studies may not detect liver injury, and DILI becomes very often apparent after the drug is launched to the market. Specific biomarkers for DILI prediction or diagnosis are not available. Toxic liv...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813176/ https://ncbi.nlm.nih.gov/pubmed/26938524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17030313 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|